# Aprepitant Effects in Intravenous Heroin Dependence

> **NCT01527994** · PHASE1 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 64 (actual)

## Conditions studied

- Opioid Dependence

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Placebo pill

## Key facts

- **NCT ID:** NCT01527994
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-06
- **Final completion:** 2015-02
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2021-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01527994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01527994, "Aprepitant Effects in Intravenous Heroin Dependence". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT01527994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*